- Report
- January 2026
- 200 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- November 2025
- 94 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Report
- November 2025
- 140 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- November 2025
- 101 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Report
- January 2026
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- January 2026
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- June 2026
- 205 Pages
United States
From €2245EUR$2,500USD£1,918GBP
- Report
- May 2026
- 110 Pages
United States
From €4266EUR$4,750USD£3,644GBP
- Report
- August 2024
- 269 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- August 2023
- 272 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- July 2025
- 136 Pages
Global
From €4177EUR$4,650USD£3,568GBP
- Report
- April 2022
- 148 Pages
Global
From €4940EUR$5,500USD£4,220GBP
- Report
- April 2025
- 125 Pages
Global
From €5344EUR$5,950USD£4,565GBP
- Report
- November 2024
- 90 Pages
United States
From €5344EUR$5,950USD£4,565GBP
- Report
- May 2024
- 80 Pages
United States
From €3548EUR$3,950USD£3,031GBP
- Report
- August 2025
- 187 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2025
- 185 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2025
- 198 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- November 2022
- 119 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- January 2024
- 200 Pages
Global
From €4491EUR$5,000USD£3,836GBP

The Whole Blood market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic products derived from living organisms. Whole Blood is a type of biopharmaceutical product that is derived from human blood, and is used to treat a variety of medical conditions. Whole Blood is typically collected from healthy donors and processed to remove any potential contaminants. It is then stored and distributed to medical facilities for use in transfusions and other treatments.
Whole Blood is used to treat a variety of medical conditions, including anemia, trauma, and cancer. It is also used to replace lost blood during surgery, and to treat patients with severe blood loss due to trauma or illness. Whole Blood is also used in research and development, as it can provide valuable insights into the human body and its response to various treatments.
Some of the major companies in the Whole Blood market include CSL Behring, Grifols, Octapharma, and Kedrion. These companies are involved in the collection, processing, storage, and distribution of Whole Blood products. Show Less Read more